Additionally, in contrast to previous studies reporting a positive correlation between TRPV2 expression and high risk of relapse in triple-negative breast cancer [74], our study demonstrated higher TRPV2 expression specifically in more advanced tumor stages, particularly stage 3, which has not been previously reported. The gene discussed is TRPV2; the disease is triple-negative breast carcinoma.